GnRH agonist
Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis
... the GnRH agonist was according to the agent prescribed and information on testosterone levels was collected when ...on GnRH was not strict for inclusion in our analysis, but generally expected to ...
16
Original Article GnRH agonist enhances autophagy in a mouse model of adenomyosis
... Seventy-five days after the final tamoxifen administration [17, 21], the 12 mice exposed to tamoxifen were randomly divided into two groups: six mice received a single intraperito- neal depot injection of the GnRH ...
8
Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis
... on GnRH therapy was defined as a rising PSA or appear- ance of new metastases on imaging despite standard, regular GnRH agonist ...available GnRH antagonist for prostate cancer patients, ...
6
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
... of GnRH analogues on oocyte morphology and quality remains ...the GnRH-ant group than in the GnRH-a group ...short GnRH-a protocols as com- pared with long-term ...the GnRH ...
10
<p>Oxidative stress and biochemical markers in prenatally androgenized sheep after neonatal treatment with GnRH agonist</p>
... supported by the literature. A group of androgenized female sheep was administered i.m. injection of a GnRH agonist (leuprolide acetate depot 7.5 mg) before 48 hours of life. All lambs were weaned at 3–4 ...
7
Effect of Pre-ovulatory Single Dose GnRH Agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study
... Therefore, administration of a single-dose GnRH agonist (0.2 mg triptorelin) on the day of hCG trigger in antagonist cycles lead to a small but non-significant improvement in clinical pregnancy and live ...
7
GnRH agonist triggering affects the kinetics of embryo development: a comparative study
... hCG-triggered embryos. Unfortunately, we could not evaluate the relationship between these differences in early developmental kinetics and pregnancy rates be- cause we did not use embryo developmental kinetics for embryo ...
6
Effects of GnRH agonist treatment on steroidogenesis and folliculogenesis in the ovary of cyclic mice
... of GnRH, known as GnRH analogs, have been synthesized in an attempt to develop more potent GnRH compounds for therapeutic ...of GnRH have been synthesized. Both GnRH agonist ...
13
Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
... the GnRH agonist ...the GnRH antagonist group (Table 3). GnRH antagonists act through competi- tive binding to GnRH receptors, a situation that can be reversed by ...to GnRH ...
7
GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)
... between GnRH-ant and GnRH-a was not significantly different (OR ...of agonist protocol (fixed or flexible GnRH-ant ...following GnRh ant compared with GnRh agonist ...
8
A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)
... Pituitary down-regulation with GnRH agonist, nafarelin (Synarel; Pharmacia, UK) starts on day 21 of the men- strual cycle. Nafarelin nasal spray is taken at a dose of two sniffs, twice a day, where one ...
9
What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?
... Briefly, all cycles were synchronised using oral contracep- tive (OC) pre-treatment. The time of OC usage could vary (minimum of 18 and maximum of 35 days) to synchronise the menstrual cycles of the patients in the ...
7
Ovulatory and Reproductive Characteristics of Sows Treated with an Intravaginal GNRH Agonist Gel
... concentrations of 4.2 – 23.1 ng/ml (Van De Weil et al., 1981, Prunier et al., 1987). In this study, the peak concentrations of LH averaged 3.2 ng/ml. Prunier (1987) reported the length of the LH surge to be between 13 ...
76
GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
... hormone agonist (GnRH-a) trigger has been used for the induction of final follicular maturation and ovulation with the aim of reducing the OHSS ...of GnRH agonist in in vitro fertilization ...
10
Triggering final follicular maturation- hCG, GnRH-agonist or both, when and to whom?
... the GnRH- antagonist with GnRH-agonist (GnRHa) trigger for final follicular matur- ...combines GnRH antagonist co-treatment and GnRHa trigger has since become a common tool aiming to eliminate ...
6
A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles
... previous menstrual cycle. Then they were randomly divided into two groups. Agonist group was treated from the 21 st day of cycle with the GnRH agonist (Suprefact, Hoechst, Germany) 500µg/day, S.C. ...
5
Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocol
... Materials and Methods: The study group included all infertile women who referred to Yazd Research and Clinical Center for Infertility. Overall 20-35 years old women who were candidate for frozen-thawed embryo transfer ...
6
Original Article Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles
... (GnRH) agonist and antagonist protocol are effective in suppressing the incidence of premature luteinizing hormone (LH) surges through reversibly blocking the secretion of pituitary gonadotropins, the exact ...
8
GnRH Agonist and GnRH Antagonist in Intracytoplasmic Injection Cycles
... of GnRH agonist and antagonist in a retrospective study of IVF/ICSI carried out in a tertiary teaching hospital from 2003 to ...68%. GnRH agonist and antagonist cycle parameters were ...
5
Suboptimal response to GnRH-agonist trigger during oocyte cryopreservation: a case series
... a GnRH antagonist protocol (Cetrotide 250 mcg daily) with recombinant FSH ...A GnRH agonist trigger (buserelin ...a GnRH-a trigger for the majority of oncofertility cases to mitigate the risk ...
6